GE HealthCare Technologies Inc GEHC Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$69.57 down $0.78, 1.11% at close Oct 16
Last close · Previous close $70.35
- Market cap
- At the Oct 16 close
- P/E ratio
- 15.96On last 12 months’ EPS
- Diluted EPS
- $4.36Last 12 months
- Dividend yield
- 0.20%Last 12 months
Price chart
$69.57down $0.78, 1.11%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$70.35Oct 15
- Volume3.11MOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume3.90MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $58.75 to $89.77; now $69.57
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
GEHC beat the S&P 500 in 2 of 5 periods.
| Period | GEHC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | GEHC: up 9.6% S&P 500: up 1.5% | GEHC beat the S&P 500 by 8.1 percentage points Beat |
| 3M | GEHC: up 6.0% S&P 500: up 1.9% | GEHC beat the S&P 500 by 4.1 percentage points Beat |
| YTD | GEHC: down 15.1% S&P 500: up 12.8% | GEHC trailed the S&P 500 by 27.9 percentage points Trailed |
| 1Y | GEHC: down 5.0% S&P 500: up 16.8% | GEHC trailed the S&P 500 by 21.8 percentage points Trailed |
| Long term | ||
| 3Y | GEHC: up 4.6% S&P 500: up 81.5% +1.5% vs +22.0% a year | GEHC trailed the S&P 500 by 76.9 percentage points Trailed |
$10,000 invested in GEHC a year ago (Oct 16, 2025) would be worth about $9,499 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,678.
GEHC beat the S&P 500 in 2 of 5 periods.
| Period | GEHC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | GEHC: up 9.6% S&P 500: up 1.2% | GEHC beat the S&P 500 by 8.4 percentage points Beat |
| 3M | GEHC: up 5.9% S&P 500: up 1.7% | GEHC beat the S&P 500 by 4.2 percentage points Beat |
| YTD | GEHC: down 15.2% S&P 500: up 11.9% | GEHC trailed the S&P 500 by 27.1 percentage points Trailed |
| 1Y | GEHC: down 5.2% S&P 500: up 15.5% | GEHC trailed the S&P 500 by 20.7 percentage points Trailed |
| Long term | ||
| 3Y | GEHC: up 4.0% S&P 500: up 75.0% +1.3% vs +20.5% a year | GEHC trailed the S&P 500 by 71.0 percentage points Trailed |
$10,000 invested in GEHC a year ago (Oct 16, 2025) would be worth about $9,481 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $11,553.
All-time high
$93.87
Closing high on . Now 25.9% below that record.
Split-adjusted daily closes since Jan 4, 2023.
Stock splits
GEHC hasn’t split since its price history begins in 2023.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $21.27Bup 6.5%
- Net income
- $1.99Bdown 11.4%
- Diluted EPS
- $4.36down 10.7%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $4.86B | $470.00M | $1.02 |
| Q4 FY24 (Dec 31, 2024) | $5.32B | $721.00M | $1.57 |
| Q1 FY25 (Mar 31, 2025) | $4.78B | $564.00M | $1.23 |
| Q2 FY25 (Jun 30, 2025) | $5.01B | $486.00M | $1.06 |
| Q3 FY25 (Sep 30, 2025) | $5.14B | $446.00M | $0.98 |
| Q4 FY25 (Dec 31, 2025) | $5.70B | $589.00M | $1.29 |
| Q1 FY26 (Mar 31, 2026) | $5.13B | $389.00M | $0.85 |
| Q2 FY26 (Jun 30, 2026) | $5.30B | $561.00M | $1.24 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $17.59B | $2.25B | $4.95 |
| FY22 (Dec 31, 2022) | $18.34B | $1.92B | $4.22 |
| FY23 (Dec 31, 2023) | $19.55B | $1.57B | $3.03 |
| FY24 (Dec 31, 2024) | $19.67B | $1.99B | $4.34 |
| FY25 (Dec 31, 2025) | $20.63B | $2.08B | $4.55 |
Margins
- Gross 39.5%
- Operating 12.9%
- Net 9.3%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $1.58BLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$2.10BLast 12 months
- Capital spending$522.00MLast 12 months
- 7.4%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $374.00MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$64.00MLast 12 months
- Total returned$438.00MLast 12 months
28% of free cash flow
Balance sheet
- $2.11BAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$10.09BAs of Jun 30, 2026
- Net debt$7.99BAs of Jun 30, 2026
- 1.26As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.92As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 5 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✗Long-term debt fell relative to assets: not passed
- ✓Current ratio improved: passed
- ✓Share count didn’t rise: passed
- ✗Gross margin improved: not passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- 18.9%Last 12 months
Over the last 12 months, GE HealthCare Technologies’s net income was 18.9% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 5.4%Last 12 months
Over the last 12 months, GE HealthCare Technologies’s net income was 5.4% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.000 |
| 2017 | $0.000 |
| 2018 | $0.000 |
| 2019 | $0.000 |
| 2020 | $0.000 |
| 2021 | $0.000 |
| 2022 | $0.000 |
| 2023 | $0.090 |
| 2024 | $0.12 |
| 2025 | $0.14 |
| 2026 (to date) | $0.11 |
Dividend details
- $0.14Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- Dividend yield0.20%Last 12 months
- $0.035Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyQuarterly4 payments in the last 12 months
- 1 yearThrough 2025
How many calendar years in a row the full-year amount has risen, through 2025.
- 3.2%Last 12 months
The share of earnings paid out as dividends over the last 12 months. Lower ratios leave more room to reinvest or raise the dividend.
Payout = Dividends per share ÷ Diluted EPS (both last 12 months)Payout ratio calculator
About GE HealthCare Technologies Inc
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies ™.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Illinois, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
GEHC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
GEHC stock FAQ
What is GEHC stock’s price today?
GE HealthCare Technologies (GEHC) traded at $69.57 at the close on , down $0.78 (1.11%) from the previous close of $70.35. Over the past 52 weeks it has traded between $58.75 and $89.77.
What is GEHC’s P/E ratio?
GEHC trades at 16.0 times its diluted earnings over the four quarters to ($4.36 per share), at the close. (How the P/E ratio works.)
How much revenue does GE HealthCare Technologies make?
GE HealthCare Technologies reported $21.3 billion of revenue over the four quarters to , up 6.5% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $5.3 billion, up 5.8% from a year earlier.
Is GE HealthCare Technologies profitable?
Yes. GE HealthCare Technologies earned $2.0 billion of net income over the four quarters to , a net margin of 9.3%, and its operating margin was 12.9% (what margins tell you).
What are GEHC’s earnings per share?
GEHC’s diluted earnings per share were $4.36 over the four quarters to , compared with $4.88 in the twelve months before. The latest quarter (Q2 FY26) brought $1.24 per share, against $1.06 a year earlier (how EPS works).
Does GEHC pay a dividend?
Yes. GE HealthCare Technologies pays a quarterly dividend. The most recent was $0.035 per share, with an ex-dividend date of . Over the last twelve months it paid $0.14 per share, a 0.20% yield at the close (how dividend yield works).
Based on the last 12 months’ payments ($0.14 per share), and if the next 12 months match the last 12, 100 shares would receive about $14 over 12 months, and $1,000 over 12 months would take about 7,143 shares, roughly $496,939 at the close. Dividends can change.
What is GEHC’s 52-week high and low?
Over the past 52 weeks GEHC has traded as low as $58.75 and as high as $89.77. At $69.57 at the close on , it is 22.5% below that high and 18.4% above the low.
What is GEHC’s all-time high?
GEHC’s highest closing price was $93.87 on , adjusted for stock splits. At $69.57 at the close on , it is 25.9% below that record.
Has GEHC stock ever split?
No. GEHC hasn’t split since its price history begins in 2023.
How has GEHC stock performed?
Including dividends and measured to the close on , GEHC has returned −15.1% so far this year and −5.0% over the past year. Over the same periods the S&P 500, measured by SPY, returned +12.8% and +16.8%. Past performance doesn’t predict future returns.
What sector and industry is GE HealthCare Technologies in?
GE HealthCare Technologies is in the Healthcare sector and the Health Information Services industry, and is headquartered in Illinois, USA.
What exchange does GEHC trade on?
GE HealthCare Technologies trades on the Nasdaq under the ticker symbol GEHC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.